Objectives: To describe the clinical features and survival of patients with retinoblastoma treated at the National Institute of Neoplastic Diseases (INEN) over a period of 07 years. The information included gender, laterality, and diagnosis age, presenting signs, place of origin, reference medical center and survival rate. Methods: Descriptive, observational, retrospective and cross-sectional study was carried out. We reviewed 220 patients with retinoblastoma treated at the INEN Results: The average age was 2.4 years. Of these (75 %) had unilateral presentation and (25 %) bilateral; six cases had family history. The most common presenting signs were leukokoria (56.36%), amaurosis (10.45%) and proptosis (9.55%). 91 patients were from Lima, 129 from provinces. The patients were classified according to the TNM (Tumour, Node and Metastesis) classification in stage I: 5 patients, stage II: 93...

Objectives: To describe the clinical features and survival of patients with retinoblastoma treated at the National Institute of Neoplastic Diseases (INEN) over a period of 07 years. The information included gender, laterality, and diagnosis age, presenting signs, place of origin, reference medical center and survival rate. Methods: Descriptive, observational, retrospective and cross-sectional study was carried out. We reviewed 220 patients with retinoblastoma treated at the INEN Results: The average age was 2.4 years. Of these (75 %) had unilateral presentation and (25 %) bilateral; six cases had family history. The most common presenting signs were leukokoria (56.36%), amaurosis (10.45%) and proptosis (9.55%). 91 patients were from Lima, 129 from provinces. The patients were classified according to the TNM (Tumour, Node and Metastesis) classification in stage I: 5 patients, stage II: 93...